Barclays’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
30,895
+12,624
+69% +$454K ﹤0.01% 2629
2026
Q1
$587K Sell
18,271
-51,831
-74% -$1.91M ﹤0.01% 3094
2025
Q4
$2.69M Buy
70,102
+5,595
+9% +$123K ﹤0.01% 2711
2025
Q3
$886K Sell
64,507
-23,624
-27% -$277K ﹤0.01% 3441
2025
Q2
$1.14M Buy
88,131
+35,762
+68% +$372K ﹤0.01% 3252
2025
Q1
$589K Sell
52,369
-18,513
-26% -$243K ﹤0.01% 3426
2024
Q4
$929K Buy
70,882
+7,516
+12% +$193K ﹤0.01% 3421
2024
Q3
$2.53M Buy
63,366
+54,932
+651% +$2M ﹤0.01% 2657
2024
Q2
$249K Buy
+8,434
New +$230K ﹤0.01% 3457

Other funds holding PACS

Barclays's PACS Position: Q2 2026 in Review

Barclays increased its PACS Group (PACS) stake by 69% in Q2 2026, buying an estimated $454K and bringing the position to 30,895 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2629.

Barclays first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.69M in Q4 2025. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Barclays held 30,895 shares of PACS Group worth $1.32M as of Q2 2026.
  • Barclays bought 12,624 PACS Group shares in Q2 2026, an estimated $454K.
  • PACS Group made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2629 holding.
  • Barclays first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • Barclays's PACS Group position peaked at $2.69M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.